Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Lovosice

8 clinical trials in Lovosice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Lovosice at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Lovosice

Open in trial search

Asthma

Recruiting

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Asthma

Not yet recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Lovosice

What the registry says about research in the country

01 Respiratory Disease Management

Innovative research focusing on chronic obstructive pulmonary disease (COPD) treatments, evaluating new therapeutic approaches to reduce moderate and severe exacerbations in patients with varying disease severity.

  • COPD Exacerbation Prevention
  • Triple Therapy Enhancement
  • Maintenance Treatment Optimization

Studies aim to improve quality of life for patients with chronic respiratory conditions through targeted interventions.

02 Severe Asthma Research

Comprehensive investigations into severe eosinophilic asthma, testing novel compounds and combination therapies to reduce exacerbation frequency and improve symptom control.

  • Exacerbation Reduction Strategies
  • Innovative Drug Development
  • Long-term Treatment Efficacy

Research focuses on developing more effective treatments for patients with inadequately controlled asthma.

03 Advanced Respiratory Therapeutics

Evaluation of combination inhalation therapies for both asthma and COPD, investigating new delivery systems and medication combinations to enhance treatment outcomes.

  • Inhaler Technology Innovation
  • Medication Combination Studies
  • Treatment Response Assessment

Clinical trials aim to advance respiratory care through improved delivery systems and targeted therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.